Sinopep shares plunge 18.61% after FDA alert halts U.S. peptide shipments
AI Summary- Sinopep Pharma stopped U.S. peptide API shipments after joining the FDA's Import Alert 66-40 list.
- 18.61%: Sinopep shares fell to 19.99 yuan, with a 19.79-yuan intraday low.
- FDA inspectors recorded eight observations during Sinopep Pharma's August Chengdu facility inspection.